Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALDR | ANAB | RXRX | ||
| Company | Alder Biopharma | Anaptysbio Inc | Recursion Pharmaceuticals Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.95 | 55.16 | 3.04 | ||
| High | 19.12 | 55.16 | 3.09 | ||
| Low | 18.83 | 53.26 | 2.92 | ||
| Latest | 18.88 | 54.15 | 2.96 | ||
| Change | -0.04 | -0.76 | -0.05 | ||
| % Change | -0.21% | -1.38% | -1.66% | ||
| Volume | 29,121,700 | 486,800 | 16,530,301 | ||
| 20-Day Average Volume | 5,270,225 | 885,905 | 25,258,814 | ||
| Previous Close | 18.92 | 54.91 | 3.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.86 | 60.97 | 3.40 | ||
| 20-Day Raw Stochastic | 48.94% | 20.94% | 9.60% | ||
| 20-Day Relative Strength | 79.65 | 45.50 | 42.01 | ||
| Weighted Alpha | -4.50 | +137.84 | -52.91 | ||
| Today's Opinion | 88% Buy | 56% Buy | 72% Sell | ||
| Previous Opinion | 88% Buy | 56% Buy | 72% Sell | ||
| Last Month's Opinion | 24% Buy | 72% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.21% since 10/14/19 | -6.64% since 07/17/26 | +0.51% since 07/17/26 | ||
| Low | 18.83 on 10/21/19 | 49.71 on 07/21/26 | 2.84 on 07/20/26 | ||
| High | 19.12 on 10/21/19 | 59.09 on 07/20/26 | 3.09 on 07/24/26 | ||
| 1-Month | |||||
| %Chg | +1.29% since 09/20/19 | -7.40% since 06/24/26 | -8.36% since 06/24/26 | ||
| Low | 18.60 on 09/23/19 | 49.71 on 07/21/26 | 2.84 on 07/20/26 | ||
| High | 19.12 on 10/21/19 | 70.91 on 07/14/26 | 4.09 on 07/06/26 | ||
| 3-Month | |||||
| %Chg | +92.26% since 07/19/19 | -8.03% since 04/24/26 | -15.67% since 04/24/26 | ||
| Low | 8.39 on 09/09/19 | 49.71 on 07/21/26 | 2.77 on 05/19/26 | ||
| High | 19.12 on 10/21/19 | 72.36 on 05/05/26 | 4.09 on 07/06/26 | ||
| 6-Month | |||||
| %Chg | +48.90% since 04/18/19 | +70.86% since 01/23/26 | -37.42% since 01/23/26 | ||
| Low | 8.39 on 09/09/19 | 29.83 on 01/30/26 | 2.77 on 05/19/26 | ||
| High | 19.12 on 10/21/19 | 72.36 on 05/05/26 | 4.74 on 01/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,582,842 | 1,603,273 | 1,568,519 | ||
| Shares Outstanding, K | 83,837 | 29,608 | 529,905 | ||
| Annual Sales | 0 | 234,600,000 | 74,680,000 | ||
| Annual Net Income | -296,430,000 | -13,230,000 | -644,760,000 | ||
| Last Quarter Sales | N/A | 25,560,000 | 6,470,000 | ||
| Last Quarter Net Income | N/A | -52,880,000 | -117,500,000 | ||
| 60-Month Beta | 2.64 | 0.68 | 1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.84 on 05/12/26 | -0.22 on 05/06/26 | ||
| Earnings Date | 11/04/19 | 08/05/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||